New tricks
Breaking news from Day 3 of ESCRS
The Flexivue System, a breakthrough implantable micro-lens treatment for presbyopia from Presbia Coöperatief was unveiled at the show and it is keenly anticipated that it will be in clinical trials in several European countries by the end of the year.
The news broke at today's show that Alcon is to gain access to proprietary antibody fragment technology particularly suited to treat eye diseases with its plan to acquire ESBATech AG, a Swiss biotechnology firm.
Rayner, the world's first IOL manufacturer, unveiled a dynamic new brand identity at ESCRS and held a seminar today to highlight the success doctors are having with its range of toric IOLs. Headlined A Roadmap to Success the seminar featured presentations from seven European doctors relating their experiences of using Rayner's toric IOLs.
More news from the congress
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.











































